Alkermes Gets $194M Award Against Janssen Approved
A New York federal judge on Friday confirmed an unopposed arbitration award against Janssen Pharmaceutical N.V. that required the Johnson & Johnson subsidiary to pay more than $194 million in back...To view the full article, register now.
Already a subscriber? Click here to view full article